MAVIS LOWE: Open Payments
NPI 1578836987 · PIKEVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$730 in 40 payments from 14 companies in 2025. Trend: 2023 $829 · 2024 $856 · 2025 $730
Food & beverage: $730
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $151 |
| Novo Nordisk Inc | 8 | $139 |
| Dexcom, Inc. | 3 | $99 |
| Abbott Laboratories | 5 | $82 |
| BETA BIONICS, INC. | 2 | $45 |
| Tandem Diabetes Care, Inc. | 1 | $40 |
| Merck Sharp & Dohme LLC | 2 | $40 |
| Merz Pharmaceuticals, LLC | 1 | $24 |
| Baxter Healthcare | 1 | $24 |
| Corcept Therapeutics | 1 | $18 |
Products named: Ozempic, JARDIANCE, Dexcom G6 Transmitter, FREESTYLE LIBRE 3, iLet Bionic Pancreas, t:slim X2 Insulin Pump with Control-IQ, ZERBAXA, Xeomin.
Industry payments across KY — which companies pay providers there.
